Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
Clinical trial NCT05013554 · TERMINATED
Trial details
- NCT number
- NCT05013554
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-16
- Primary completion
- 2024-01-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.